Apr 13, 2022 12:02PM

Mar 7, 2022 11:56AM

Dec 20, 2021 12:11PM

Nov 8, 2021 08:00AM

Feb 12, 2021 04:06PM

Feb 12, 2021 04:05PM

Feb 11, 2021 08:07AM Urovant Sciences (UROV) Announces Progression of URO-902 Phase 2a Trial Following Positive Recommendation from the Data and Safety Monitoring Board

Feb 11, 2021 08:00AM

Dec 23, 2020 04:08PM

Dec 23, 2020 04:06PM

Dec 23, 2020 04:05PM

Dec 23, 2020 02:58PM

Nov 24, 2020 04:15PM

Nov 24, 2020 04:05PM Urovant Sciences Announces Topline Data from Phase 2a Study of Vibegron for the Treatment of Irritable Bowel Syndrome (IBS) Pain Did Not Meet Primary Endpoint

Nov 19, 2020 08:05AM

Nov 19, 2020 08:00AM

Nov 12, 2020 05:18PM

Nov 12, 2020 05:18PM

Nov 12, 2020 05:00PM

Nov 10, 2020 08:00AM

Nov 2, 2020 04:05PM Urovant Sciences Reports Second Quarter Fiscal Year 2020 Results

Oct 27, 2020 08:00AM

Oct 7, 2020 08:09AM

Oct 7, 2020 08:00AM

Sep 8, 2020 08:00AM

Aug 13, 2020 04:05PM

Aug 6, 2020 08:00AM

Jun 19, 2020 09:24PM Sumitovant Biopharma Announces Urovant Sciences Collaboration with Sunovion Pharmaceuticals

Jun 18, 2020 04:08PM

Jun 18, 2020 04:05PM

Jun 18, 2020 08:03AM

Jun 18, 2020 08:00AM

Jun 11, 2020 08:00AM

Jun 2, 2020 08:00AM

May 27, 2020 08:08AM Urovant Sciences (UROV) Names James Hindman to Board

May 27, 2020 08:00AM

May 26, 2020 08:00AM

May 14, 2020 08:00AM

Mar 23, 2020 04:06PM

Mar 23, 2020 04:05PM

Mar 5, 2020 08:02AM

Mar 5, 2020 08:00AM Urovant Sciences Announces U.S. FDA Acceptance of New Drug Application for Vibegron for the Treatment of Overactive Bladder

Mar 2, 2020 08:03AM

Mar 2, 2020 08:00AM

Feb 25, 2020 08:00AM

Feb 13, 2020 04:39PM

Feb 13, 2020 04:15PM

Feb 6, 2020 08:00AM

Feb 4, 2020 08:00AM Urovant Sciences Announces Publication of Results from Phase 1 Clinical Trials Evaluating URO-902 Gene Therapy in Patients with Overactive Bladder

Jan 17, 2020 08:00AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All